These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
609 related articles for article (PubMed ID: 31311773)
1. Correlation Between Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773 [TBL] [Abstract][Full Text] [Related]
2. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT. Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064 [TBL] [Abstract][Full Text] [Related]
3. A preliminary study to propose a diagnostic algorithm for PET/CT-detected incidental breast lesions: application of BI-RADS lexicon for US in combination with SUVmax. Bakhshayeshkaram M; Salehi Y; Abbasi M; Hashemi Beni R; Seifi S; Hassanzad M; Jamaati HR; Aghahosseini F Eur Radiol; 2019 Oct; 29(10):5507-5516. PubMed ID: 30887201 [TBL] [Abstract][Full Text] [Related]
4. The role of the breast radiologist in evaluation of breast incidentalomas detected on 18-fludeoxyglucose positron emission tomography/CT. Dunne RM; O'Mahony D; Wilson G; McDermott R; O'Keeffe SA Br J Radiol; 2013 Jun; 86(1026):20130034. PubMed ID: 23568361 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of Zhang Y; Han J; Li J; Cao J; Zhou Y; Deng S; Zhang B; Yang Y J Cancer Res Clin Oncol; 2024 May; 150(5):265. PubMed ID: 38769201 [TBL] [Abstract][Full Text] [Related]
6. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458 [TBL] [Abstract][Full Text] [Related]
7. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology. Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545 [TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T. Magometschnigg HF; Baltzer PA; Fueger B; Helbich TH; Karanikas G; Dubsky P; Rudas M; Weber M; Pinker K Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1656-1665. PubMed ID: 26121928 [TBL] [Abstract][Full Text] [Related]
10. The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions. Sa R; Zhao HG; Dai YY; Guan F Medicine (Baltimore); 2018 Sep; 97(38):e12521. PubMed ID: 30235771 [TBL] [Abstract][Full Text] [Related]
11. Incidental focal colorectal ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography. Cho SH; Kim SW; Kim WC; Park JM; Yoo IeR; Kim SH; Oh ST World J Gastroenterol; 2013 Jun; 19(22):3453-8. PubMed ID: 23801838 [TBL] [Abstract][Full Text] [Related]
12. Differentiation and diagnosis of benign and malignant testicular lesions using 18F-FDG PET/CT. Shao D; Gao Q; Tian XW; Wang SY; Liang CH; Wang SX Eur J Radiol; 2017 Aug; 93():114-120. PubMed ID: 28668404 [TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose PET/computed tomography in locoregional staging and assessment of biological and clinical aggressiveness of breast cancer subtypes. Ozkan EE; Sengul SS; Erdogan M; Gurdal O; Eroglu HE Nucl Med Commun; 2019 Oct; 40(10):1043-1050. PubMed ID: 31425343 [TBL] [Abstract][Full Text] [Related]
14. The clinical value of texture analysis of dual-time-point Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan. Suga K; Kawakami Y; Hiyama A; Matsunaga N Ann Nucl Med; 2009 Jun; 23(4):399-407. PubMed ID: 19452249 [TBL] [Abstract][Full Text] [Related]
16. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics. Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193 [TBL] [Abstract][Full Text] [Related]
17. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature. Guan ZW; Xu BX; Wang RM; Sun L; Tian JH Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644 [TBL] [Abstract][Full Text] [Related]